Management of chronic back and leg pain by intrathecal drug delivery.

[1]  S. Onesti.  Failed Back Syndrome , 2004, The neurologist.

[2]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.

[3]  E. Kravitz,et al.  Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study , 2004, Pain.

[4]  L. Tonder,et al.  Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. , 2004, Pain medicine.

[5]  R. Penn.  Intrathecal medication delivery. , 2003, Neurosurgery clinics of North America.

[6]  S. Hassenbusch,et al.  Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. , 2002, Pain medicine.

[7]  S. Hassenbusch,et al.  Management of intrathecal catheter-tip inflammatory masses: a consensus statement. , 2002, Pain medicine.

[8]  F. Phillips,et al.  Managing Chronic Pain of Spinal Origin After Lumbar Surgery: The Role of Decompressive Surgery , 2002, Spine.

[9]  Y. E. Mironer,et al.  Efficacy and Safety of Intrathecal Opioid/Bupivacaine Mixture in Chronic Nonmalignant Pain: A Double Blind, Randomized, Crossover, Multicenter Study by the National Forum of Independent Pain Clinicians (NFIPC) , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[10]  Krishna Kumar,et al.  Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. , 2002, Journal of neurosurgery.

[11]  E. Vresilovic,et al.  Etiologies of failed back surgery syndrome. , 2002, Pain medicine.

[12]  D. Caraway,et al.  Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. , 2002, The spine journal : official journal of the North American Spine Society.

[13]  S. Hassenbusch,et al.  Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. , 2002, Pain medicine.

[14]  N. Rainov,et al.  Making a Case for Programmable Pumps Over Fixed Rate Pumps for the Management of Fluctuations in Chronic Pain and Spasticity: A Literature Review , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[15]  J. Schofferman,et al.  Etiology of long-term failures of lumbar spine surgery. , 2002, Pain medicine.

[16]  L. J. Roberts,et al.  Outcome of intrathecal opioids in chronic non‐cancer pain , 2001, European journal of pain.

[17]  N. Rainov,et al.  Long-term intrathecal infusion of drug combinations for chronic back and leg pain. , 2001, Journal of pain and symptom management.

[18]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[19]  M. Kelly,et al.  Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. , 2001, Surgical neurology.

[20]  S. Hassenbusch,et al.  Evidence-based review of the literature on intrathecal delivery of pain medication. , 2000, Journal of pain and symptom management.

[21]  S. Hassenbusch,et al.  PolyAnalgesic consensus conference 2000 , 2000, Journal of pain and symptom management.

[22]  S. Hassenbusch,et al.  Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000. , 2000, Journal of pain and symptom management.

[23]  K. Jain,et al.  Addition of intrathecal midazolam to bupivacaine produces better post-operative analgesia without prolonging recovery. , 1999, International journal of clinical pharmacology and therapeutics.

[24]  E. Krames.  Practical issues when using neuraxial infusion. , 1999, Oncology.

[25]  J. Neal,et al.  The neurotoxicity of drugs given intrathecally (spinal) , 1999, Anesthesia and analgesia.

[26]  K J Burchiel,et al.  A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. , 1999, Neurosurgery.

[27]  W. Winkelmüller,et al.  Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. , 1996, Journal of neurosurgery.

[28]  R. Portenoy,et al.  Opioid therapy for chronic nonmalignant pain: a review of the critical issues. , 1996, Journal of pain and symptom management.

[29]  R. Penn,et al.  Intraspinal morphine for chronic pain: a retrospective, multicenter study. , 1996, Journal of pain and symptom management.

[30]  S. Hassenbusch,et al.  Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. , 1995, Journal of pain and symptom management.

[31]  H. Wulf,et al.  The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. , 1994, Journal of Pain and Symptom Management.

[32]  R. Kanoff.  Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin , 1994, The Journal of the American Osteopathic Association.

[33]  S. Morley,et al.  Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study , 1992, Pain.

[34]  R. Penn,et al.  Chronic intrathecal morphine for intractable pain. , 1987, Journal of neurosurgery.

[35]  H. Jick,et al.  Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.

[36]  Ruth E. Brown,et al.  Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. , 1997, Clinical therapeutics.

[37]  R. Portenoy.  Opioid therapy for chronic nonmalignant pain , 1996 .